Useful predictors of progression-free survival for Japanese patients with LATITUDE-high-risk metastatic castration-sensitive prostate cancer who received upfront abiraterone acetate.
Kiyoshi TakaharaTaku NaikiToshiki ItoKeita NakaneTakuya KoieTakahiro YasuiHideaki MiyakeRyoichi ShirokiPublished in: International journal of urology : official journal of the Japanese Urological Association (2021)
Upfront abiraterone acetate might provide satisfactory outcomes for Japanese patients with LATITUDE-high-risk metastatic castration-sensitive prostate cancer. Gleason pattern 5, performance status and hemoglobin are potential predictors of progression-free survival in Japanese patients with LATITUDE-high-risk metastatic castration-sensitive prostate cancer who received upfront abiraterone acetate.